This mechanism has been validated at multiple levels: histological analyses of clinical tissues show significantly increased NF-κB activity in both the pulmonary arteriolar lesions and AMs of PAH patients (94); single-cell sequencing further confirms sustained activation of this pathway in MCT- and Su/Hx-induced rat models (95). This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.